GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alimera Sciences Inc (FRA:ASZ1) » Definitions » Other Current Liabilities

Alimera Sciences (FRA:ASZ1) Other Current Liabilities : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Alimera Sciences Other Current Liabilities?

Alimera Sciences's other current liabilities for the quarter that ended in Mar. 2024 was €0.00 Mil.

Alimera Sciences's quarterly other current liabilities increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€3.17 Mil) but then declined from Dec. 2023 (€3.17 Mil) to Mar. 2024 (€0.00 Mil).

Alimera Sciences's annual other current liabilities increased from Dec. 2021 (€1.93 Mil) to Dec. 2022 (€2.17 Mil) and increased from Dec. 2022 (€2.17 Mil) to Dec. 2023 (€3.17 Mil).


Alimera Sciences Other Current Liabilities Historical Data

The historical data trend for Alimera Sciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alimera Sciences Other Current Liabilities Chart

Alimera Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alimera Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alimera Sciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Alimera Sciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Alimera Sciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Alimera Sciences (FRA:ASZ1) Business Description

Traded in Other Exchanges
Address
6310 Town Square, Suite 400, Alpharetta, GA, USA, 30005
Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East.

Alimera Sciences (FRA:ASZ1) Headlines

No Headlines